SGLT2 inhibitors reduce cardiovascular and renal events through mechanisms largely independent of weight loss, a consideration for patients whose clinical risk profile extends beyond adiposity alone
Insurance companies have been known to stop coverage for GLP-1 injectable therapy when they consider a person with diabetes to be stable or in remission, often using the hemoglobin A1C lab results as the sole criterion
Independent certificates of analysis (COAs) provide crucial verification of product quality and authenticity
Genetics Some people are simply more prone to hyperpigmentation due to their genetic makeup and skin type
The 5-on/2-off schedule, the bedtime timing, the 3-month cycle with a rest period, the reconstitution method: none of these are suggestions
Of course, individual results depend on factors like diet, exercise, and starting weight